|
P-016: Tumor profiling of idecabtagene vicleucel (ide-cel, bb2121) patients in KarMMa showed comparable responses in existing molecular high-risk subsets and preliminary gene signature of durable response |
|
|
|
Titel: |
P-016: Tumor profiling of idecabtagene vicleucel (ide-cel, bb2121) patients in KarMMa showed comparable responses in existing molecular high-risk subsets and preliminary gene signature of durable response |
Auteur: |
Martin, Nathan Xu, Amy Stong, Nicholas Rytlewski, Julie Finney, Olivia Campbell, Timothy Pierceall, William Flynt, Erin Thompson, Ethan Kaiser, Shari |
Verschenen in: |
Clinical lymphoma myeloma and leukemia |
Paginering: |
Jaargang 22 () nr. S pagina's S44-S45 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|